Fiesta Restaurant Group (FRGI) was the Fund's best performing position in the fourth quarter and for all of 2013. Over the past year the stock g ained over 240 percent and added 212 basis points of return. The fast-food chain has con tinued to restructure after spinning off Burger King restaurants and is now successfully ach ieving organic growth. We continue to believe the stock is undervalued and expect further growth ahead.
From John Keeley (Trades, Portfolio)'s Keeley All Cap Value Fund fourth quarter 2013 commentary.
Also check out: John Keeley Undervalued Stocks John Keeley Top Growth Companies John Keeley High Yield stocks, and Stocks that John Keeley keeps buying
Currently 3.00/512345
Rating: 3.0/5 (1 vote)
Subscribe via Email Subscribe RSS Comments Please leave your comment:More GuruFocus Links Latest Guru Picks Value Strategies Warren Buffett Portfolio Ben Graham Net-Net Real Time Picks Buffett-Munger Screener Aggregated Portfolio Undervalued Predictable ETFs, Options Low P/S Companies Insider Trends 10-Year Financials 52-Week Lows Interactive Charts Model Portfolios DCF Calculator RSS Feed Monthly Newsletters The All-In-One Screener Portfolio Tracking Tool MORE GURUFOCUS LINKS Latest Guru Picks Value Strategies Warren Buffett Portfolio Ben Graham Net-Net Real Time Picks Buffett-Munger Screener Aggregated Portfolio Undervalu
Top 5 Asian Companies To Buy For 2015: Ruby Tuesday Inc.(RT)
Ruby Tuesday, Inc., together with its subsidiaries, develops, operates, and franchises casual dining restaurants in the United States, Puerto Rico, Guam, and internationally. The company operates its restaurants under the Ruby Tuesday brand, as well as owns and operates one Marlin & Ray?s, one Truffles, and two Wok Hay casual dining restaurants. As of August 30, 2011, it owned and operated 746 Ruby Tuesday restaurants; and 43 domestic and 52 international franchisees operated restaurants. The company was founded in 1920 and is based in Maryville, Tennessee.
Advisors' Opinion:- [By Rupert Hargreaves]
It is safe to say that Ruby Tuesday� (NYSE: RT ) has not had a good year so far. Year-to-date, the company's share price has fallen 3.5%, and it is down 23% from its 52-week high. In addition, the company has not been profitable for the last two years. However, I believe that Ruby still has plenty going for it.
Top Industrial Disributor Stocks To Invest In 2014: Banner Corporation(BANR)
Banner Corporation operates as the holding company for Banner Bank and Islanders Bank that provide commercial banking and financial products and services to individuals, businesses, and public sector entities. It generates various deposit instruments, including demand checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, regular savings accounts, certificates of deposit, cash management services, and retirement savings plans. The company also originates commercial business and commercial real estate loans, agricultural business loans, construction and land development loans, one to four-family residential loans, and consumer loans. In addition, it engages in mortgage banking operations primarily through the origination and sale of one to four-family residential loans. As of December 31, 2010, Banner Bank operated 86 branch offices and 7 loan production offices in Washington, Oregon, and Idaho; and Islanders Bank conducted business from 3 locations in San Juan County, Washington. The company was founded in 1890 and is based in Walla Walla, Washington.
Advisors' Opinion:- [By Marc Bastow]
Bank holding company Banner (BANR) raised its quarterly dividend 20% to 18 cents per share, payable April 15 to shareholders or record as of April 7.
BANR Dividend Yield: 1.75%
Top Industrial Disributor Stocks To Invest In 2014: Reliance Steel & Aluminum Co.(RS)
Reliance Steel & Aluminum Co. operates as a metals service center company primarily in the United States and Canada. The company provides metals processing services and distributes a line of approximately 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium, and specialty steel products to mills and original equipment manufacturers. Its processing services comprise cutting, leveling, sawing, machining, or electropolishing. The company also offers a range of metal perforating and fabrication services; and steel and alloy pipes, tube and bar products, and precision manufacturing of various tools designed for the global energy service companies. Reliance Steel & Aluminum Co. serves manufacturers and end-users in the general manufacturing, non-residential construction, transportation, aerospace, energy, electronics, and semiconductor fabrication and related industries. As of December 31, 2011, it maintained approximately 220 metals service center processing and distribution facilities in the United States, Belgium, Canada, China, Malaysia, Mexico, Singapore, South Korea, the United Arab Emirates, and the United Kingdom. The company was founded in 1939 and is headquartered in Los Angeles, California.
Advisors' Opinion:- [By Dan Caplinger]
Reliance Steel & Aluminum (NYSE: RS ) : up 100%
The steel industry has been struggling lately, so it's especially remarkable to see Reliance Steel having made not one but two dividend increases in the past year. With increases from $0.15 per share last May to $0.25 in August and then to $0.30 in March, Reliance is bucking the negative trends in steel. What's especially noteworthy is that the company raised its payout even after announcing more than a $750 million deal to buy Metals USA in February -- a move that might have led other companies to rein in its payouts. - [By Kelley Wright]
Reliance Steel & Aluminum (RS)��ielding 1.8%.
The Timely Ten is comprised of stocks from the Undervalued category, based on dividend parameters. They generally have an S&P Dividend & Earnings Quality ranking of A- or better, and show exemplary long-term dividend growth.
- [By Monica Gerson]
Reliance Steel & Aluminum Co (NYSE: RS) is estimated to report its Q3 earnings at $1.20 per share on revenue of $2.54 billion.
PulteGroup (NYSE: PHM) is expected to report its Q3 earnings at $0.36 per share on revenue of $1.46 billion.
Top Industrial Disributor Stocks To Invest In 2014: Covidien PLC (COV)
Covidien Public Limited Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates its businesses through three segments: Medical Devices, which includes the development, manufacture and sale of endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products; Pharmaceuticals, which includes the development, manufacture and distribution of specialty pharmaceuticals and active pharmaceutical ingredients, and Medical Supplies, SharpSafety products and original equipment manufacturer products. In May 2012, it acquired Newport Medical Instruments, Inc. In May 2012, it acquired superDimension, Ltd. In June 2012, the Company acquired Oridion Systems Ltd. In October 2012, its Mallinckrodt acquired CNS Therapeutics, Inc. In January 2013, the Company acquired CV Ingenuity. Advisors' Opinion:- [By Dan Caplinger]
Yet the episode led to criticism of Intuitive Surgical in other arenas. Last month, the president of a major group of OB/GYNs said that using robotic systems for hysterectomy procedures -- a significant area of potential growth for the company -- lacked data showing its usefulness and made procedures far more expensive. That could reduce sales and have an impact not just toward the end of last quarter but for future periods as well. Moreover, you can expect traditional medical-instrument makers Johnson & Johnson (NYSE: JNJ ) and Covidien (NYSE: COV ) to step in to take advantage of the situation, as they stand to benefit substantially if robotics are shown to be inferior. Both J&J and Covidien supply more traditional instruments and supplies for surgical procedures, and regulators are more familiar with their safety profiles.
Top Industrial Disributor Stocks To Invest In 2014: Theragenics Corporation(TGX)
Theragenics Corporation operates as a medical device company serving the cancer treatment and surgical products markets primarily in the United States and Europe. It operates through two segments, Surgical Products and Brachytherapy Seed. The Surgical Products segment manufactures, markets, and sells disposable devices primarily utilized in surgical procedures. It offers wound closure products, including sutures, needles, and other surgical products; vascular access products comprising introducer sheaths, guidewires, and accessories; and specialty needles consisting of coaxial, biopsy, brachytherapy, guidewire introducer, spinal, and disposable veress, as well as access trocars and other needle-based products. This segment?s products are used in various markets and applications, such as interventional cardiology and radiology, vascular surgery, orthopedics, plastic surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery. The Brachytherapy See d segment manufactures, markets, and sells TheraSeed and I-Seed, which are FDA-cleared devices for treatment of solid localized tumors and localized prostate cancer. The company sells its products primarily to physicians, hospitals and other healthcare providers, original equipment manufacturers, and to a network of distributors. Theragenics Corporation was founded in 1981 and is based in Buford, Georgia.
Advisors' Opinion:- [By James E. Brumley]
I hate to be the one to say I told you so, but, I told you so. Back on February 26th I suggested IsoRay, Inc. (NYSEMKT:ISR) shares were a budding breakout play. The 48% rally that's played out for ISR in the meantime unfurled right on cue. While overbought in the very short run, this small cap stock looks like it's earning the right to be compared to the likes of bigger brothers in the cancer-treatment space... names like Roche Holding Ltd. (OTCMKTS:RHHBY) or Theragenics Corporation (NYSE:TGX).
Top Industrial Disributor Stocks To Invest In 2014: XOMA Ltd.(XOMA)
XOMA Ltd., a biopharmaceutical company, engages in the discovery, development, and manufacture of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. Its products under development include gevokizumab, an anti-inflammatory monoclonal antibody that inhibits interleukin-1 beta and has completed Phase 2 development stage for the treatment of Behcet?s uveitis, as well as is in Phase 2b clinical trail for Type 2 diabetes with cardiovascular biomarkers; XOMA 3AB, a biodefense anti-botulism product candidate comprising a combination or cocktail of antibodies for the treatment of botulism poisoning; and preclinical antibody discovery programs in various indications, including autoimmune, cardio-metabolic, inflammatory, and oncological diseases. The company, through its collaboration agreement with Novartis AG, is also developing HCD122, a human anti-CD40 antagonist antibody that is in Phase 1/2 clinical trial for the treatment of B-cell mediated diseases, including malignancies and autoimmune diseases; and LFA102, which is in Phase 2 clinical trial for the treatment of hematologic tumors and other undisclosed diseases. In addition, it licenses proprietary technologies relating to bacterial expression of recombinant pharmaceutical products to biotechnology and pharmaceutical companies. The company has collaboration agreements with Les Laboratoires Servier; National Institute of Allergy and Infectious Diseases; SRI International; Takeda Pharmaceutical Company Limited; Novartis AG; Arana Therapeutics Limited; Kaketsuken; Genentech, Inc.; and UCB Celltech. XOMA Ltd. was founded in 1981 and is headquartered in Berkeley, California.
Advisors' Opinion:- [By Lisa Levin]
XOMA (NASDAQ: XOMA) shares gained 7.55% to $4.70 in the pre-market session on encouraging Phase 2 Gevokizumab results.
Central European Media Enterprises (NASDAQ: CETV) soared 5.67% to $2.98 in the pre-market trading. Central European Media shares have tumbled 48.07% over the past 52 weeks, while the S&P 500 index has gained 23.52% in the same period.
- [By Lisa Levin]
XOMA (NASDAQ: XOMA) shares reached a new 52-week high of $8.61. XOMA shares have jumped 196.09% over the past 52 weeks, while the S&P 500 index has gained 25.27% in the same period.
Top Industrial Disributor Stocks To Invest In 2014: PetroChina Company Limited(PTR)
PetroChina Company Limited produces and distributes oil and gas in the People?s Republic of China. It operates in four segments: Exploration and Production, Refining and Chemicals, Marketing, and Natural Gas and Pipeline. The Exploration and Production segment explores, develops, produces, and markets crude oil and natural gas, oilsands, and coalbed methane. As of December 31, 2010, it had 11,278 million barrels of proved reserves of crude oil; and 65,503 billion cubic feet of proved reserves of natural gas. The Refining and Chemicals segment engages in the refining of crude oil and petroleum products; and production and marketing of petrochemical products, derivative petrochemical products, and other chemical products. This segment?s product line comprises processed crude oil, gasoline, kerosene, diesel, ethylene, synthetic resins, synthetic fiber materials, polymers, synthetic rubber, and urea. The Marketing segment involves in the marketing of refined products and tradi ng businesses. It operated 17,996 service stations. The Natural Gas and Pipeline segment engages in the transmission of natural gas, crude oil, and refined products; and the sale of natural gas. It had a total length of 56,840 kilometers (km) of oil and gas pipelines, including 32,801 km of natural gas pipelines, 14,782 km of crude oil pipelines, and 9,257 km of refined product pipelines. The company was founded in 1988 and is headquartered in Beijing, the People?s Republic of China. PetroChina Company Limited is a subsidiary of China National Petroleum Corporation.
Advisors' Opinion:- [By Jonas Elmerraji]
First up is Chinese oil and gas giant PetroChina (PTR). Saying PetroChina has seen a rough 2013 is an understatement. Year-to-date, shares of the $203 billion firm have slipped more than 22% at the same time that the S&P 500 has been in rally mode. But shareholders could be in store for a reprieve this winter thanks to a bullish setup that's been forming in shares of late.
PetroChina is currently forming an ascending triangle bottom, a trading setup that's formed by a horizontal resistance level to the upside at $118 and uptrending support below shares. Basically, as PTR bounces between those two levels, it's getting squeezed closer and closer to a breakout above the $118 price ceiling. When that breakout happens, it's time to be a buyer.
Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. Triangles and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable. Instead, it all comes down to supply and demand for shares.
That $28 resistance level is a price where there has been an excess of supply of shares; in other words, it's a place where sellers had been more eager to step in and take gains than buyers were to buy. That's what makes this week's breakout above it so significant. The move means that buyers are finally strong enough to absorb all of the excess supply above that price level.
If you decide to take the Pandora trade, I'd recommend keeping a protective stop at the 50-day moving average.
No comments:
Post a Comment